Medtech company behind home analysis of blood tests to enter stock exchange in Spring

A brand new Danish medtech company with 20 years of research and experience behind it is entering the stock exchange in March, where it wants to raise DKK 32 million (USD 4.7 million) to kickstart sales of a new product, which aims to make it easier to monitor and diagnose illlnesses.

Thomas Warthoe, CEO of Qlife, is taking the company to the Swedish stock exchange next year. Photo: Photo: Qlife

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles